Physician profile
Amy Marlo Haddock
NPI 1275976862
$2,481.72
in general payments reported to CMS, 2019-2025
29 companies · $503 in 2025
The $503 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $491 · 2020: $161 · 2021: $509 · 2022: $211 · 2023: $422 · 2024: $185 · 2025: $503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,109.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $445.50 | 2019-2025 | Aptima, Coolseal Generator, Acessa Provu System |
| Astellas Pharma US INC | $284.27 | 2023-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $221.33 | 2019-2023 | |
| Abbvie INC. | $209.63 | 2019-2023 | |
| Gynesonics, INC. | $160.58 | 2021 | |
| Sumitomo Pharma America, INC. | $157.68 | 2023-2025 | Myfembree, Gemtesa |
| Channel Medsystems, INC. | $139.00 | 2025 | |
| Roche Diagnostics Corporation | $74.90 | 2019-2021 | |
| Coopersurgical, INC. | $68.27 | 2019-2022 | |
| Lupin INC. | $64.22 | 2019-2020 | |
| Ethicon US, LLC | $61.14 | 2022 | |
| Mayne Pharma Commercial LLC | $58.61 | 2022-2023 | |
| Daiichi Sankyo INC. | $57.26 | 2020-2021 | |
| Medicem INC. | $54.58 | 2021-2022 | |
| Duchesnay USA Incorporated | $49.38 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $47.93 | 2019-2020 | |
| Asensus Surgical, INC. | $38.15 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $36.72 | 2019-2023 | Exparel |
| Therapeuticsmd, INC. | $35.88 | 2021-2022 | |
| Lsi Solutions INC | $34.05 | 2025 | Fornisee |
| Glaxosmithkline, LLC. | $30.52 | 2019-2023 | Shingrix, Boostrix |
| Organon LLC | $28.15 | 2022 | |
| Boston Scientific Corporation | $24.35 | 2025 | Axonics |
| Sanofi Pasteur INC. | $21.62 | 2025 | |
| Sage Therapeutics, LLC | $20.62 | 2024 | |
| Medtronic, INC. | $15.60 | 2021 | |
| Avion Pharmaceuticals | $14.99 | 2023 | Balcoltra |
| Merck Sharp & Dohme LLC | $14.16 | 2019 | |
| Allergan, INC. | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Haddock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.